Because BTHS is an X-linked recessive disorder caused by mutations in the TAZ gene located on a chromosome1,56, the therapeutic effect of mitochondrial transplantation may be limited and gene therapy for the TAZ gene mutation may be necessary to fully restore mitochondrial function in BTHS CMs. The gene discussed is TAFAZZIN; the disease is Barth syndrome.